LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
May 4, 2020
Deals
Stemline takeout gives Menarini U.S. oncology beachhead
Read More
BioCentury
|
Jan 25, 2019
Clinical News
FDA panel backs Takeda's gout drug Uloric for some patient populations
Read More
BioCentury
|
Aug 10, 2018
Company News
Ironwood ends gout drug deal with AZ
Read More
BioCentury
|
Aug 6, 2018
Company News
Ironwood ends gout drug deal with AZ
Read More
BioCentury
|
Aug 28, 2017
Clinical News
FDA approves Ironwood's Duzallo for gout
Read More
BioCentury
|
Aug 21, 2017
Company News
FDA approves Ironwood's gout combo
Read More
BioCentury
|
Apr 18, 2017
Distillery Therapeutics
Autoimmune disease
Read More
BioCentury
|
Jan 13, 2017
Clinical News
Duzallo regulatory update
Read More
BioCentury
|
Oct 10, 2016
Company News
Ironwood sales and marketing update
Read More
BioCentury
|
Jun 3, 2016
Company News
AstraZeneca continues to divest Zurampic rights
Read More
Items per page:
10
1 - 10 of 103
